Prestige Biologics Corrects Disclosure on 28.8 Billion KRW Deposit for COVID-19 Vaccine Contract Manufacturing Agreement
[Asia Economy Reporter Ji Yeon-jin] Prestige Biologics corrected on the 26th that the contract amount for the contract manufacturing of the Sputnik Light vaccine, a COVID-19 vaccine developed in Russia, is 28.8 billion KRW. Previously, the company had announced the contract amount as 2.88 trillion KRW the day before.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Sold Everything Fearing Bankruptcy, Then It Soared 3,900 Times: How a Stock Once Feared for Delisting Became an AI Powerhouse"
- "All Major Corporations Could Leave"... Business Community Fears Overseas Factory Relocation Due to Strike Risks
- Man in His 50s Steals 71 Million Won From Former Coworker's Family Home Safe After Break-In 10 Years After Working Together
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
